Pfizer share price today

(PFE)

Pfizer share price is $26.3 & ₹2,275.27 as on 18 Jan 2025, 2.30 'hrs' IST

$26.3

▲

-0.19

(-0.72%)

Market is closed - opens 8 PM, 21 Jan 2025

View live Pfizer share price in Dollar and Rupees. Guide to invest in Pfizer stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Pfizer, along with analyst recommendations, forecasts, and comprehensive financials.

Pfizer share price movements

Today's Low: $26.27
Today's High: $26.55
$26.30
0.11%
Downside
Day's Volatility :1.05%
Upside
0.94%
52 Weeks Low: $24.48
52 Weeks High: $31.54
$26.30
6.92%
Downside
52 Weeks Volatility :22.38%
Upside
16.61%

Pfizer Returns

Period	Pfizer Inc.	Sector (Health Care)	S&P500
3 Months	-9.09%	-8.5%	2.3%
6 Months	-11.15%	-5.2%	8.9%
1 Year	-7.1%	0.5%	23.9%
3 Years	-50.18%	7.2%	33.8%

Pfizer Key Statistics

in dollars & INR

Previous Close	$26.49
Open	$26.395
Today's High	$26.5499
Today's Low	$26.27
Market Capitalization	$149.0B
Today's Volume	$31.5M
52 Week High	$31.54
52 Week Low	$24.48
Revenue TTM	$59.4B
EBITDA	$18.4B
Earnings Per Share (EPS)	$0.75
PE Ratio	35.07
Dividend Yield	6.54%
Profit Margin	7.16%
Quarterly Earnings Growth YOY	-0.98%
Return On Equity TTM	4.54%

How to invest in Pfizer from India?

It is very easy for Indian residents to invest directly in Pfizer from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Pfizer stock in both Indian Rupees (INR) and US Dollars (USD). Search for Pfizer or PFE on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Pfizer or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Pfizer shares which would translate to 0.033 fractional shares of Pfizer as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Pfizer, in just a few clicks!

Returns in Pfizer for Indian investors in Rupees

Investment Value

₹1,00,000

Pfizer investment value today

Current value as on today

₹97,018

Returns

₹2,982

(-2.98%)

Returns from Pfizer Stock

₹7,100 (-7.1%)

Dollar Returns

₹4,118 (+4.12%)

Indian investors sentiment towards Pfizer

-44.75%

Period: Oct 21, 2024 to Jan 19, 2025. Change in 30 Days versus previous period

Investment in Pfizer from India has reduced in the last 30 days as on Jan 20, 2025. -44.75% less purchase transactions for Pfizer in the last 30 days versus the previous period.

-1%

Period: Oct 21, 2024 to Jan 19, 2025. Change in 30 Days versus previous period

Search volume for Pfizer on INDmoney from India has reduced in the last 30 days as on Jan 20, 2025. -1% less investors are searching Pfizer in the last 30 days versus the previous period.

Indian Mutual Funds that invest in Pfizer

Name	Shares Held	Change in Shares	% of Assets
ICICI Prudential US Bluechip Equity Fund Direct Plan Growth	337963	-88360.43	2.38%
Motilal Oswal S&P 500 Index Fund Direct Growth	48887	-2084.05	0.30%

Global Institutional Holdings in Pfizer

Vanguard Group Inc
9.11%
BlackRock Inc
7.69%
State Street Corp
5.13%
Wellington Management Company LLP
2.89%
Charles Schwab Investment Management Inc
2.30%
Geode Capital Management, LLC
2.08%

Analyst Recommendation on Pfizer

Hold

43%Buy

56%Hold

0%Sell

Based on 30 Wall street analysts offering stock ratings for Pfizer(by analysts ranked 0 to 5 stars)

Based on 30 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Pfizer

What analysts predicted

Upside of 18.54%

Target:

$31.18

Current:

$26.30

Insights on Pfizer

Price Movement
In the last 7 days, PFE stock has moved down by -1.9%
Increasing Revenue
Pfizer Inc. has experienced consistent revenue growth over the last two quarters. In the most recent quarter, the revenue rose to $17.70 billion, up from $13.28 billion in the previous quarter. This represents an average increase of 25.0% per quarter.
Increasing Net Profit
Pfizer Inc. has shown impressive profit growth over the last two quarters. The net profit increased from $24.0 million to $4.46 billion, reflecting an average increase of 99.5% per quarter.
PFE vs PG (1 yr)
In the last 1 year, Procter & Gamble Company, The has given 9.2% return, outperforming this stock by 16.2%
PFE vs PG (3 yr)
In the last 3 years, Pfizer Inc. has experienced a drawdown of -51.3%, however Procter & Gamble Company, The resisted the overall trend and outperformed by 50.8%
Price to Sales
Pfizer Inc. has a Price-to-Sales (P/S) Ratio of 2.5, meaning that investors are willing to pay $2.5 for every $1 of sales the company generates. In comparison, Procter & Gamble Company has a higher P/S Ratio of 4.5, indicating that investors are willing to pay more — $4.5 for every $1 of sales. This suggests that investors currently value Pfizer Inc. less in relation to its sales when compared to Procter & Gamble.

Pfizer Financials in INR & Dollars

	FY18	Y/Y Change
Revenue	$53.6B	↑ 2.1%
Net Income	$11.2B	↓ 47.66%
Net Profit Margin	20.79%	↓ 19.76%

	FY19	Y/Y Change
Revenue	$51.8B	↓ 3.54%
Net Income	$16.3B	↑ 45.91%
Net Profit Margin	31.45%	↑ 10.66%

	FY20	Y/Y Change
Revenue	$41.9B	↓ 19.02%
Net Income	$7.0B	↓ 56.86%
Net Profit Margin	16.75%	↓ 14.7%

	FY21	Y/Y Change
Revenue	$81.3B	↑ 93.97%
Net Income	$22.0B	↑ 213.09%
Net Profit Margin	27.04%	↑ 10.29%

	FY22	Y/Y Change
Revenue	$100.3B	↑ 23.43%
Net Income	$31.4B	↑ 42.74%
Net Profit Margin	31.27%	↑ 4.23%

	FY23	Y/Y Change
Revenue	$58.5B	↓ 41.7%
Net Income	$2.1B	↓ 93.25%
Net Profit Margin	3.62%	↓ 27.65%

	Q2 FY23	Q/Q Change
Revenue	$12.7B	↓ 30.35%
Net Income	$2.3B	↓ 58.02%
Net Profit Margin	18.27%	↓ 12.05%

	Q3 FY23	Q/Q Change
Revenue	$13.2B	↑ 3.91%
Net Income	$-2.4B	↓ 202.88%
Net Profit Margin	-18.09%	↓ 36.36%

	Q4 FY23	Q/Q Change
Revenue	$14.2B	↑ 7.69%
Net Income	$-3.3B	↑ 39.68%
Net Profit Margin	-23.47%	↓ 5.38%

	Q1 FY24	Q/Q Change
Revenue	$14.9B	↑ 4.42%
Net Income	$3.1B	↓ 193.15%
Net Profit Margin	20.94%	↑ 44.41%

	Q2 FY24	Q/Q Change
Revenue	$13.3B	↓ 10.73%
Net Income	$24.0M	↓ 99.23%
Net Profit Margin	0.18%	↓ 20.76%

	Q3 FY24	Q/Q Change
Revenue	$17.7B	↑ 33.27%
Net Income	$4.5B	↑ 18504.17%
Net Profit Margin	25.22%	↑ 25.04%

	FY18	Y/Y Change
Profit	$42.4B	↑ 2.65%

	FY19	Y/Y Change
Profit	$41.5B	↓ 2.05%

	FY20	Y/Y Change
Profit	$33.2B	↓ 20.02%

	FY21	Y/Y Change
Profit	$50.5B	↑ 51.94%

	FY22	Y/Y Change
Profit	$66.0B	↑ 30.75%

	FY23	Y/Y Change
Profit	$28.8B	↓ 56.34%

	Q2 FY23	Q/Q Change
Profit	$9.5B	↓ 22.38%

	Q3 FY23	Q/Q Change
Profit	$2.6B	↓ 72.32%

	Q4 FY23	Q/Q Change
Profit	$5.7B	↑ 115.18%

	Q1 FY24	Q/Q Change
Profit	$10.5B	↑ 85.58%

	Q2 FY24	Q/Q Change
Profit	$8.2B	↓ 21.48%

	Q3 FY24	Q/Q Change
Profit	$11.1B	↑ 34.99%

	FY18	Y/Y Change
Operating Cash Flow	$15.8B	↓ 3.9%
Investing Cash Flow	$4.5B	↓ 195.44%
Financing Cash Flow	$-20.4B	↑ 56.82%

	FY19	Y/Y Change
Operating Cash Flow	$12.6B	↓ 20.47%
Investing Cash Flow	$-3.9B	↓ 187.18%
Financing Cash Flow	$-8.5B	↓ 58.49%

	FY20	Y/Y Change
Operating Cash Flow	$14.4B	↑ 14.42%
Investing Cash Flow	$-4.3B	↑ 8.26%
Financing Cash Flow	$-9.6B	↑ 13.72%

	FY21	Y/Y Change
Operating Cash Flow	$32.6B	↑ 126.2%
Investing Cash Flow	$-22.5B	↑ 427.89%
Financing Cash Flow	$-9.8B	↑ 1.73%

	FY22	Y/Y Change
Operating Cash Flow	$29.3B	↓ 10.17%
Investing Cash Flow	$-15.8B	↓ 30.0%
Financing Cash Flow	$-14.8B	↑ 51.12%

	FY23	Y/Y Change
Operating Cash Flow	$8.7B	↓ 70.27%
Investing Cash Flow	$-32.3B	↑ 104.51%
Financing Cash Flow	$26.1B	↓ 275.72%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$-1.2B	↓ 199.67%
Investing Cash Flow	$-25.5B	↓ 868.78%
Financing Cash Flow	$27.2B	↓ 1080.66%

	Q3 FY23	Q/Q Change
Operating Cash Flow	$3.5B	↓ 386.09%
Investing Cash Flow	$888.0M	↓ 103.48%
Financing Cash Flow	$-3.8B	↓ 113.91%

	Q4 FY23	Q/Q Change
Operating Cash Flow	$5.2B	↑ 51.62%
Investing Cash Flow	$-11.0B	↓ 1338.29%
Financing Cash Flow	$5.4B	↓ 244.01%

	Q1 FY24	Q/Q Change
Operating Cash Flow	$1.1B	↓ 79.18%
Investing Cash Flow	$1.7B	↓ 115.75%
Financing Cash Flow	$-4.9B	↓ 190.61%

Pfizer Technicals Summary

Sell

Neutral

Buy

Pfizer is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Pfizer Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Pfizer Inc.	-1.54%	-11.15%	-7.1%	-50.18%	-34.56%
Procter & Gamble Company, The	-4.15%	-4.23%	8.97%	-0.92%	27.57%
Johnson & Johnson	1.21%	-4.67%	-9.5%	-10.82%	-0.82%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Pfizer Inc.	35.07	35.07	0.2	2.93	0.05	0.03	0.07	16.29
Procter & Gamble Company, The	27.78	27.78	3.41	6.93	0.29	0.11	0.03	21.68
Johnson & Johnson	24.34	24.34	0.86	9.97	0.21	0.08	0.03	29.14

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Pfizer Inc.	Hold	$149.0B	-34.56%	35.07	7.16%
Procter & Gamble Company, The	Buy	$379.5B	27.57%	27.78	17.06%
Johnson & Johnson	Buy	$354.0B	-0.82%	24.34	16.74%

Pfizer Dividend announcements

Pfizer Dividends March, 2025
In the quarter ending March,2025. Pfizer has declared dividend of $0.43
Read More

About Pfizer

“Pfizer Inc., founded in 1849 by Charles Pfizer and Charles F. Erhart, is an American Biotechnology and Pharmaceutical giant. It is currently headquartered in New York City, United States with worldwide operations and distributions. To ensure that the medicinal and vaccine requirements of every patient and individual are met, Pfizer has been adopting a rigorous and scientific approach towards its supply chain. They now have a network of 58 manufacturing sites around the world under Pfizer Global Supply (PGS). To further expand its operations in the research and pharmaceutical sphere, it entered various merger and acquisitions deals with other players including Wyeth, Pharmacia, Warner-Lambert, Innopharma, etc. Its primary focus areas include internal medicine, rare diseases, vaccines, inflammation, immunology, oncology, and anti-infectives. They have major R&D platforms in the fields of gene therapy, precision medicine, biosimilars, medicinal sciences, and maternal immunizations. Pfizer Is traded under the ticker symbol of PFE. The financials of Pfizer are as follows: While Pfizer clocked a revenue of $41.908 billion for 2020, its net income amounted to $6985 million for the same period. Pfizer has made significant contributions in the fight against Covid-19 and has been successful in the early development of the Pfizer-BioNTech Vocid-19 vaccine. In 2020, Pfizer achieved the Top Employer Certification for the 5th year in the UK. Going by the revenue, Pfizer is the 4th largest pharmaceutical company globally and the 3rd largest in terms of market capitalization. It is currently traded in NYSE and other indices, including S&P 100, S&P 500, and Russell 1000 Index. Currently Pfizer Inc. has a market cap of $162.74 Billion. It has a P.E ratio of -62.69. The shares of Pfizer Inc. are trading at $26.3. ” .

Organization	Pfizer
Employees	88000
CEO	Dr. Albert Bourla D.V.M., Ph.D.
Industry	Health Technology

Management People of Pfizer

Name	Title
Dr. Albert Bourla D.V.M., Ph.D.	Chairman of the Board & CEO
Mr. David M. Denton	Chief Financial Officer & Executive VP
Mr. Douglas M. Lankler	Executive VP & Chief Legal Officer
Ms. Jennifer B. Damico	Senior VP, Controller & Principal Accounting Officer
Ms. Lidia L. Fonseca	Executive VP and Chief Digital & Technology Officer
Dr. Chris Boshoff FMedSci, M.D., Ph.D.	Chief Scientific Officer and President of Research & Development
Ms. Francesca M. DeMartino	Chief Investor Relations Officer
Ms. Payal Sahni Becher	Chief People Experience Officer & Executive VP
Ms. Sally M. Susman	Executive VP & Chief Corporate Affairs Officer
Dr. Michael S. Vincent M.D., Ph.D.	Senior VP and Chief Scientific Officer of Inflammation & Immunology

Important FAQs about investing in Pfizer from India :

What is Pfizer share price today?

Pfizer share price today stands at $26.30, Open: $26.40 ; Previous Close: $26.49 ; High: $26.55 ; Low: $26.27 ; 52 Week High: $31.54 ; 52 Week Low: $24.48. The stock opens at $26.40, after a previous close of $26.49. The stock reached a daily high of $26.55 and a low of $26.27, with a 52-week high of $31.54 and a 52-week low of $24.48.

Can Indians buy Pfizer shares?

Yes, Indians can invest in the Pfizer (PFE) from India.

With INDmoney, you can buy Pfizer at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Pfizer at zero transaction cost.

How can I buy Pfizer shares from India?

It is very easy to buy Pfizer from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Pfizer be purchased?

Yes, you can buy fractional shares of Pfizer with INDmoney app.

What are the documents required to start investing in Pfizer stocks?

To start investing in Pfizer, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.